secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001628280-24-010538
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeautyHealth Q4 net sales $96.8M (-1.3% YoY); full year net loss $100.1M
------------------------------------------------------------------------

- Full year net sales $398.0M, up 8.8% YoY; Q4 net sales $96.8M, down 1.3% YoY.
- Full year net loss $100.1M (vs $44.2M income in 2022); Q4 net loss $9.4M (vs $6.5M income).
- Full year adjusted EBITDA $24.3M (6.1% margin) vs $46.1M (12.6% margin) in 2022.
- Total delivery systems sold in Q4 1,551 vs 2,067 YoY; active install base grew 24% to 31,446.
- Adjusted gross margin fell to 54.6% in Q4 from 73.6% in prior year; full year 62.8% vs 72.6%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024010538/0001628280-24-010538-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024010538/skin-20240312.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-010538

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer